Clinical Trial Update: Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated cisplatin and gemcitabine with or without berzosertib in patients with metastatic urothelial cancer. The study has completed and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Urothelial Carcinoma
• Urothelial Carcinoma of the Renal Pelvis and Ureter

Drugs mentioned

• Berzosertib (berzosertib)
• CISPLATIN (cisplatin)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-10-17